Why Oscar Health, Inc. (OSCR) stock moved
Oscar Health, Inc. (OSCR) shares climbed 6.3% to $32.24 as of September 4, 2026, a significant gain from the prior close of $30.33. BestStocks flagged the session as a major change for OSCR. The move is tied to price move up. Below, we break down what changed for OSCR, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
OSCR climbed 6.3% to $32.24
Oscar Health shares rose 6.43% to $32.76 on Friday, August 14, 2026, extending a multi-session post-earnings run rather than reacting to a fresh same-day catalyst. The most-cited analyst move — Wells Fargo raising its price target to $27 from $20 while maintaining Equal Weight — was actually issued the prior day, Thursday, August 13, when Oscar had already gained 3.95%. The fundamental backdrop was Oscar's strong Q2 report on August 6, which showed a swing to GAAP profitability.
What it means for Oscar Health, Inc. investors
For Oscar Health, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Material positive event; Strong 6.3% price move on light volume. Weighing against that: Oscar Health, Inc. (OSCR) moved -5.72% from $30.61 to $28.86 on July 16, 2026; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $27.25, implying -15.5% downside from $32.24. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (56/100). With earnings roughly 66 days out, the next report is the most likely near-term test of the move.
OSCR price reaction
OSCR last traded at $32.24, up $1.91 (+6.30%) from the previous close of $30.33. The session traded on 0.7× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $26.54 and $32.76, and it currently sits about 92% of the way up that band.
Bullish and bearish analyst opinions on Oscar Health, Inc. (OSCR)
The consensus analyst price target on Oscar Health, Inc. (OSCR) is $27.25, 15.5% below the recent $32.24. Over the past 90 days analysts logged 1 upgrade, 3 maintains, and 0 downgrades. Here is how the bullish and bearish cases on OSCR line up.
The bullish case
- The Street's most bullish target is $39.00 (+21.0%).
- 1 analyst upgrade in the past 90 days, most recently Barclays to Overweight (2026-06-10).
- Material positive event.
- Strong 6.3% price move on light volume.
- Oscar Health, Inc. (OSCR) moved +5.28% from $26.50 to $27.90 on August 7, 2026.
The bearish case
- The consensus analyst price target of $27.25 sits 15.5% below the recent $32.24, so the average target sees limited room to run.
- The most bearish analyst target is $16.00 (-50.4%).
- Oscar Health, Inc. (OSCR) moved -5.72% from $30.61 to $28.86 on July 16, 2026.
- OSCR moved -3.60% from its $27.53 open to a $26.54 close on 2026-08-06.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 4, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for OSCR
In-depth OSCR event analyses
Frequently asked questions about OSCR
Why did Oscar Health, Inc. (OSCR) stock move?
Oscar Health shares rose 6.43% to $32.76 on Friday, August 14, 2026, extending a multi-session post-earnings run rather than reacting to a fresh same-day catalyst. The most-cited analyst move — Wells Fargo raising its price target to $27 from $20 while maintaining Equal Weight — was actually issued the prior day, Thursday, August 13, when Oscar had already gained 3.95%. The fundamental backdrop was Oscar's strong Q2 report on August 6, which showed a swing to GAAP profitability.
How much did OSCR stock rise?
OSCR gained 6.30% ($1.91) versus the prior close of $30.33, last trading at $32.24 on 0.7× average volume.
When is Oscar Health, Inc.'s next earnings date?
OSCR's next earnings report is estimated for 2026-11-09 — about 66 days away.
What is the analyst price target for OSCR?
The consensus analyst price target for OSCR is $27.25, about 15.5% below the current $32.24. Over the past 90 days, analysts recorded 1 upgrade, 3 maintains, and 0 downgrades.
How BestStocks tracks OSCR
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for OSCR, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 4, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.